FCM
IDXX icon

Fieldview Capital Management’s Idexx Laboratories IDXX Stock Holding History

Fieldview Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,871
Closed -$1.27M – 611
2025
Q4 		$1.27M Buy
+1,871
New +$1.27M 0.22% 155

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fieldview Capital Management's IDXX Position: Q1 2026 in Review

Fieldview Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 1,871 shares — an estimated $1.27M sold.

Fieldview Capital Management first reported a position in IDXX in Q4 2025 and held it in 1 quarter. The position peaked at $1.27M in Q4 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Fieldview Capital Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 1,871 Idexx Laboratories shares in Q1 2026, an estimated $1.27M.
  • Fieldview Capital Management first reported a position in Idexx Laboratories in Q4 2025 and held it in 1 quarter.
  • Fieldview Capital Management's Idexx Laboratories position peaked at $1.27M in Q4 2025.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.